Interestingly, patients with higher BMIs (>25) tended to have high Elovl6-expressing HCC, but this did not reach statistical significance ( p = 0.581).
← all excerpts
Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.
1
0.5810
0.5810